CSIMarket



Evolutionary Genomics Inc.  (FNAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Evolutionary Genomics's Working Capital Ratio for Trailing Twelve Months Period

FNAM's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

FNAM Working Capital Ratio for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Current Liabilities Growth 42624.69 % 1654.59 % -74.9 % -28.57 % -96.9 %
Y / Y Current Assets Growth 493.03 % 290.52 % -35.82 % -36.74 % 180.22 %
Working Capital Ratio for Trailing Twelve Months Period 1.17 7.38 4.7 4.12 3.41
Total Ranking # 3630 # 774 # 1294 # # 1114
Seq. Current Liabilities Growth 3046.5 % 197.07 % -85.38 % 3025.34 % 29.22 %
Seq. Current Assets Growth -14.74 % 323.79 % 510.78 % -73.13 % -43.86 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to doubling in Current Liabilities in the II. Quarter to $2 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 1.17 below Evolutionary Genomics Inc. average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Laboratories industry 43 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Evolutionary Genomics. While Working Capital Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 774 to 3630.

What is Working Capital Ratio?
More about FNAM
Working Capital Ratio FNAM in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 44
Sector # 934
S&P 500 # 3608


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
82.53 17.44 1.17
(Mar 31 2018)   (Jun 30 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Medical Laboratories Industry Working Capital Ratio for Trailing Twelve Months Period
Arrowhead Pharmaceuticals Inc.  3.12 
Tenax Therapeutics Inc.  3.09 
Bionexus Gene Lab Corp.  2.98 
Opgen Inc.  2.93 
Enzo Biochem Inc  2.92 
Pieris Pharmaceuticals Inc.  2.81 
Psychemedics Corp  2.79 
Exact Sciences Corporation  2.68 
Luna Innovations Inc  2.63 
American Shared Hospital Services  2.60 
Biodesix Inc.  2.22 
Laboratory Corporation Of America Holdings  1.92 
Charles River Laboratories International inc.  1.89 
Eventbrite Inc.  1.89 
National Research Corporation  1.78 
Intercure Ltd   1.74 
Quest Diagnostics Inc  1.69 
Iqvia Holdings Inc.  1.56 
Sorrento Therapeutics Inc.  1.51 
Inotiv inc.  1.45 
Pra Health Sciences Inc   1.21 
Icon Plc  1.19 
Ppd Inc   1.17 
Evolutionary Genomics Inc.  1.13 
Syneos Health Inc.  1.09 
Radnet Inc.  1.03 
Aurora Mobile Ltd  1.02 
Cryo cell International Inc.  0.65 
International Stem Cell Corporation  0.63 
Kraig Biocraft Laboratories Inc.  0.47 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BPSR's Profile

Stock Price

BPSR's Financials

Business Description

Fundamentals

Charts & Quotes

BPSR's News

Suppliers

BPSR's Competitors

Customers & Markets

Economic Indicators

BPSR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071